Clinical Trial Update: A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of lobaplatin and 5-fluorouracil for recurrent nasopharyngeal carcinoma; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Lobaplatin (lobaplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Recurrent Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN